NAV
$39.34
AUM
$68.5M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.93
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +5.28% | +3.67% | +6.81% | +14.08% | +11.63% | +5.92% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | NOVN.SW | Novartis AG Registered Shares | 4.93% |
| 2 | NESN.SW | Nestle SA | 4.89% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 4.51% |
| 4 | ITX.MC | Industria De Diseno Textil SA Share From Split | 3.36% |
| 5 | MC.PA | Lvmh Moet Hennessy Louis Vuitton SE | 3.35% |
| 6 | BP.L | BP PLC | 3.23% |
| 7 | BBVA.MC | Banco Bilbao Vizcaya Argentaria SA | 3.15% |
| 8 | INGA.AS | ING Groep NV | 2.66% |
| 9 | AZN.L | AstraZeneca PLC | 2.63% |
| 10 | DTE.DE | Deutsche Telekom AG | 2.56% |
At least 80% of the fund's total assets will be invested in constituent securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such constituent securities. The index consists of dividend-paying common stocks of companies with growth characteristics that are incorporated and listed on a stock exchange in one of the following countries: Germany, Switzerland, United Kingdom, etc. The fund is non-diversified.
Inception Date: 2014-05-07